Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01990937
Other study ID # PMK-031
Secondary ID
Status Recruiting
Phase Phase 4
First received October 20, 2013
Last updated October 27, 2014
Start date October 2013
Est. completion date February 2015

Study information

Verified date October 2014
Source Phramongkutklao College of Medicine and Hospital
Contact Chaipichit Puttapitakpong, Doctor
Phone 6681707-3005
Email iamkeang@hotmail.com
Is FDA regulated No
Health authority Thailand: Ethical Committee
Study type Interventional

Clinical Trial Summary

Can oral midazolam used for sedation in patients undergoing upper gastrointestinal endoscopy ?


Description:

Five mg of midazolam was intake orally about 30 minutes before undergoing perform upper gastrointestinal endoscopy. Declined of anxiety scores was primary end point.


Recruitment information / eligibility

Status Recruiting
Enrollment 260
Est. completion date February 2015
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Scheduled to undergo elective diagnostic EGD

- American Society of Anesthesia (ASA) criteria to be class 1 to 2

Exclusion Criteria:

- History of gastrectomy, esophagectomy, pancreaticoduodenectomy, or other operation on the upper-GI tract

- American Society of Anesthesia (ASA) criteria to be class 3 to 4

- Pregnancy

- Alcoholism

- Drug abuse

- Taking psychotic medications

- Allergy to midazolam.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Conscious Sedation Failure During Procedure

Intervention

Drug:
Oral midazolam
5 mg in 15 mL of apple juice, orally 30 minutes before undergoing EGD

Locations

Country Name City State
Thailand Division of Gastroenterology, Department of Medicine, Phramongkutklao hospital Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Phramongkutklao College of Medicine and Hospital

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Other Amnesia score Fully recovery means fully gain of consiouness (time, place, person).
Amnesia score was grading into 4 levels;
= Patient unable to recall any portion of procedure
= Able to recall and describe some portion of procedure
= Able to recall and describe most of procedure
= Able to recall and describe entire procedure
Asked the patient after fully recovery from sedation. No
Other Overall satisfaction Fully recovery means fully gain of consiouness (time, place, person). Overall satifaction was 10-cm scaled visual analog scale. Asked the patient after fully recovery from sedation. No
Other Willing to repeat EGD Fully recovery means fully gain of consiouness (time, place, person). Willing to repeat EGD was defined to "Yes or No". Asked the patient after fully recovery from sedation. No
Other Vital signs Vital signs were blood pressure(mmHg), heart rates(beats per minute), respiratory rates(per minute) and oxygen saturation(percents). Vital signs were measured at 5 minutes before EGD then measured every 5 minutes during EGD until the patient was fully recovery after the EGD was finished. Yes
Primary Difference of Anxiety score Anxiety score is 10-cm scaled visual analog scale.
Anxiety score which asked the patient 5 minutes before EGD, called "Pre EGD anxiety score"
Anxiety score which asked the patient after fully recovery, called "During EGD anxiety score".
Difference of anxiety score means "Pre EGD minus During anxiety score".
Fully recovery means fully gain of consiouness (time, place, person).
Asked the patient 5 minutes before EGD and then after fully recovery from sedation. No
Secondary Overall tolerance Fully recovery means fully gain of consiouness (time, place, person).
Overall tolerance was grading into 4 levels;
Poor : Very uncomfortable during the entire procedure
Fair : Uncomfortable during most of the procedure
Good : Believes the procedure was generally comfortable, there were portions of procedure during which sedation could have been given
Excellent : Believes the procedure was comfortable, no additional sedation was needed
Asked the patient after fully recovery from sedation. No
See also
  Status Clinical Trial Phase
Completed NCT02512055 - Ketamine Tolerance in Children After Repeated Administrations During Radiotherapy Sessions Phase 4
Completed NCT05115578 - Remifentanil Effect-site Prediction by Algometry
Completed NCT00902395 - Efficacy of Moderate Sedation for Dental Treatment of Young Children Phase 4
Recruiting NCT04997967 - Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis Phase 4
Completed NCT02676206 - Music Therapy in Procedural Sedation in the Emergency Department N/A
Completed NCT02820051 - Non-anesthesiologist-administered Propofol During the Flexible Bronchoscopy N/A
Recruiting NCT02205502 - Lidocaine as Local Anesthetics in Children Under Ketamine Sedation Phase 4
Completed NCT00596050 - Ketamine Versus Etomidate for Procedural Sedation for Pediatric Orthopedic Reductions Phase 4
Unknown status NCT01321047 - Balanced Propofol Sedation Versus Propofol Alone Sedation in Therapeutic Endoscopic Retrograde Cholangiopancreatography (ERCP) Phase 4